Role of exosomes in immune regulation

被引:124
作者
Li, Xiao-Bo
Zhang, Zhi-Ren
Schluesener, Hermann J.
Xu, Shun-Qing
机构
[1] Huazhong Univ Sci & Technol, Inst Environm Med, Tongji Med Coll, Wuhan 430030, Peoples R China
[2] Univ Tubingen, Inst Brain Res, Tubingen, Germany
关键词
exosomes; tumor; immunotherapy;
D O I
10.1111/j.1582-4934.2006.tb00405.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Exosomes are small vesicles originating from late endosomes, 30-100 nm in diameter with typical cup-shape morphology. They are reported to bear high levels of a narrow spectrum of molecules involved in immune response and signal transduction. Apart from removing obsolete membrane proteins, some surprising biological functions of exosomes were unveiled recently and their applications in immunotherapy of tumors are currently intensively investigated. Dendritic cell-(DC) and tumor-derived exosomes have considerable anti-tumor effects in experimental studies and several clinical trials. Despite their potential applications in eliciting a "positive" immune response, exosomes might induce some "unwanted" immune responses, such as immune tolerance and immune evasion. Therefore further investigations about the physiological functions of exosomes and the optimal way of exosome application in tumor immunotherapy are necessary. This review presents recent developments in the field of exosome research and focuses on its applications to tumor immunotherapy.
引用
收藏
页码:364 / 375
页数:12
相关论文
共 88 条
[1]   Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis [J].
Abusamra, AJ ;
Zhong, ZH ;
Zheng, XF ;
Li, M ;
Ichim, TE ;
Chin, JL ;
Min, WP .
BLOOD CELLS MOLECULES AND DISEASES, 2005, 35 (02) :169-173
[2]   Diacylglycerol kinase α regulates the secretion of lethal exosomes bearing Fas ligand during activation-induced cell death of T lymphocytes [J].
Alonso, R ;
Rodríguez, MC ;
Pindado, J ;
Merino, E ;
Mérida, I ;
Izquierdo, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (31) :28439-28450
[3]   Exosomes from plasmacytoma cells as a tumor vaccine [J].
Altieri, SL ;
Khan, ANH ;
Tomasi, TB .
JOURNAL OF IMMUNOTHERAPY, 2004, 27 (04) :282-288
[4]   Exosomes for cancer immunotherapy [J].
Andre, F ;
Escudier, B ;
Angevin, E ;
Tursz, T ;
Zitvogel, L .
ANNALS OF ONCOLOGY, 2004, 15 :141-144
[5]   Malignant effusions and immunogenic tumour-derived exosomes [J].
Andre, F ;
Schartz, NEC ;
Movassagh, M ;
Flament, C ;
Pautier, P ;
Morice, P ;
Pomel, C ;
Lhomme, C ;
Escudier, B ;
Le Chevalier, T ;
Tursz, T ;
Amigorena, S ;
Raposo, G ;
Angevin, E ;
Zitvogel, L .
LANCET, 2002, 360 (9329) :295-305
[6]   Tumor-derived exosomes:: a new source of tumor rejection antigens [J].
André, F ;
Scharz, NEC ;
Chaput, N ;
Flament, C ;
Raposo, G ;
Amigorena, S ;
Angevin, E ;
Zitvogel, L .
VACCINE, 2002, 20 :A28-A31
[7]  
Arnold PY, 1999, EUR J IMMUNOL, V29, P1363, DOI 10.1002/(SICI)1521-4141(199904)29:04<1363::AID-IMMU1363>3.0.CO
[8]  
2-0
[9]   Proteomic analysis of exosomes isolated from human malignant pleural effusions [J].
Bard, MP ;
Hegmans, JP ;
Hemmes, A ;
Luider, TM ;
Willemsen, R ;
Severijnen, LAA ;
van Meerbeeck, JP ;
Burgers, SA ;
Hoogsteden, HC ;
Lambrecht, BN .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2004, 31 (01) :114-121
[10]   Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity [J].
Basu, S ;
Srivastava, PK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05) :797-802